1

Shuqin Qiu1, Zihong Xian1, Junyu Chen2

  • 1NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.

Neuroscience letters
|January 19, 2024
PubMed
概括

核受体核心抑制剂1 (NCoR1) 缺乏通过增加PGC-1α表达来减少神经炎症. 这一发现为涉及炎症的神经退行性疾病提供了潜在的治疗点.